title: Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy.
abstract: OBJECTIVE
  To determine whether plasmin will cleave the laminin and fibronectin located at the vitreoretinal junction during plasmin-assisted vitrectomy.
  
  
  METHODS
  Western blot analyses were performed with antilaminin or anti-fibronectin antibodies on the internal limiting membranes collected from patients with macular holes or cystoid macular edema who underwent vitrectomy with or without plasmin. The results were compared with the results of in vitro experiments in which commercially available laminin and fibronectin were exposed to commercially available plasmin.
  
  
  RESULTS
  In all eyes treated with plasmin, a posterior vitreous detachment was not present before surgery but was created easily with a minimal suction of less than 100 mm Hg during vitrectomy. Western blot analyses showed that the laminin and fibronectin in the internal limiting membrane exposed to plasmin during vitrectomy were degraded to several fragments of lower molecular weights, including a fragment of approximately 13,000 Da for laminin and a fragment of approximately 30,000 Da for fibronectin. These lower-molecular-weight fragments also appeared in the in vitro experiments.
  
  
  CONCLUSIONS
  The laminin and fibronectin at the vitreoretinal junction are degraded during plasmin-assisted vitrectomy.
  
  
  CONCLUSIONS
  These findings provide evidence for the efficacy of using plasmin to create a posterior vitreous detachment during vitreoretinal surgery.
authors.affiliation: Department of Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
authors.forename: Ai
authors.initials: A
authors.lastname: Uemura
authors.forename: Makoto
authors.initials: M
authors.lastname: Nakamura
authors.forename: Shu
authors.initials: S
authors.lastname: Kachi
authors.forename: Yuji
authors.initials: Y
authors.lastname: Nishizawa
authors.forename: Tetsu
authors.initials: T
authors.lastname: Asami
authors.forename: Yozo
authors.initials: Y
authors.lastname: Miyake
authors.forename: Hiroko
authors.initials: H
authors.lastname: Terasaki
mesh_terms: D001485:Basement Membrane / Q000187:drug effects* / Q000378:metabolism; D015153:Blotting, Western; D003131:Combined Modality Therapy; D005341:Fibrinolysin / Q000494:pharmacology*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005353:Fibronectins / Q000378:metabolism*; D006801:Humans; D007797:Laminin / Q000378:metabolism*; D008269:Macular Edema / Q000601:surgery; D012167:Retinal Perforations / Q000601:surgery; D014821:Vitrectomy / Q000379:methods*; D014822:Vitreous Body / Q000187:drug effects / Q000378:metabolism
chemical_list: D005343:Fibrinolytic Agents; D005353:Fibronectins; D007797:Laminin; D005341:Fibrinolysin